DMAC
Diamedica·NASDAQ
--
--(--)
--
--(--)
5.13 / 10
Netural
Fund flow evaluation: 7.49/10 reflecting robust fund flow characteristics. Constructive Small and Large trends face headwinds from adverse overall, block, Medium, and Extra-large developments, indicating positive money flow direction. Analyst sentiment reflects overwhelmingly bullish analyst consensus with strong conviction. The rating profile includes Buy(100.0%) from 1 analytical reports, supported by 2.77 historical weighted rating.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-11-14
InstitutionCantor Fitzgerald
Times predicted1
Historical Win Rate100.0%
What is the analyst consensus for DMAC?
- DMAC holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.13/10 (Netural).
